Effects of Dual Task Training on Balance, Activity and Participation in Children With Cerebral Palsy
- Disease/Condition
- Cerebral Palsy
- Drug/Device/Intervention
- Dual task training
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Riphah International University
- Location
- Lahore, Pakistan
- Phase
- N/A
- Start date
- May 16, 2024
- End date
- Aug 01, 2024
- Enrollment
- 44 participants
Pediatric Berg Balance Scale,Time up and go test,Participation of Daily Life PODCI Questionnaire
Cerebral palsy is a non progressive neurodevelopmental disorder that usually effects the
 muscles of the patients effecting its tone, strength and eventually ability to move. Dual
 tasking training incorporates more than one task at a time, it can b either physical task
 with movement or mental tasks. Backward walking is used to challenge the proprioception.
 
 The study is a randomized controlled trial to assess the effects of Dual task training with
 and without Backward walking on balance, activity and participations on children with
 cerebral palsy. Study will be conducted in PSRD and Rehab care. Sample will be recruited
 randomly and then divided into two groups control and experimental group. Control group will
 receive dual task training and experimental group will receive both dual task training and
 backward walking. This treatment would continue for 4 weeks. Patient will be assessed both at
 the start and end of 4 weeks. The outcome tools for assessment of balance, activity and
 participation will be following: Pediatric Berg Balance Scale, Time up and Go test and
 Participation of daily life PODCI Questionnaire. Ethical consideration will be followed and
 informed consent will be taken from legal guardians.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06407765
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06407765 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 44 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.